BDSX BIODESIX INC

NEUTRAL Impact: 4/10 EFFECT
Horizon weeks Filed Jun 1, 2026 Processed 5d 12h ago SEC 9999999995-26-001816
IPO/offering going effective

Price Chart

Loading chart...

Executive Summary

Biodesix's S-3 shelf registration (File No. 333-296122) became effective on May 29, 2026, covering the resale of up to 375,000 shares of common stock issuable upon exercise of warrants held by Perceptive Credit Holdings. The shelf allows Perceptive to sell these shares at any time, creating a known overhang of ~1.4% of shares outstanding (based on ~27M shares outstanding). The cross-filing context confirms this is a shelf resale registration, not a primary offering, so the dilution risk is limited to the warrant shares already issued.

Actionable Insight

The shelf effectiveness is a routine procedural step — the warrant shares were already issued and the overhang was known. Monitor for any Form 4 filings from Perceptive indicating actual sales, which would create modest selling pressure. No immediate trading catalyst.

Key Facts

  • S-3 shelf became effective May 29, 2026, covering up to 375,000 shares for resale by Perceptive Credit Holdings
  • Shares are issuable upon exercise of warrants granted in connection with a November 2022 credit agreement (as amended multiple times)
  • This is a resale registration, not a primary offering — no new capital raised by Biodesix
  • The 375,000 shares represent approximately 1.4% of outstanding shares (estimated ~27M shares outstanding)
  • Effectiveness date is May 29, 2026; filing accepted June 1, 2026

Financial Impact

Up to 375,000 shares of common stock (approx. 1.4% dilution) available for resale by Perceptive Credit Holdings

dilutionshare count

Risk Factors

  • Perceptive could sell the 375,000 shares into the market, creating incremental selling pressure
  • If the stock price weakens, the warrant exercise may not occur, reducing the actual dilution

Market Snapshot

Exchange
Nasdaq
Sector
Services-Medical Laboratories
Analyst Consensus
91% bullish (11 analysts)

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
EFFECT Filing (Primary)9999999995-26-001816
Document: 9999999995-26-001816-index.html9999999995-26-001816
Document: 9999999995-26-001816.txt9999999995-26-001816
4 reports for BDSX
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for BDSX — sortable, filterable
Type Now
Jun 1, 2026
5d ago
EFFECT
NEUTRAL ★ 4/10
awaiting T+20
May 4, 2026
4w ago
Press Release
BULLISH ★ 8/10
$14.94 $15.44▲ +3.35%▼ −1.61%$15.46 (+3.48%)
Apr 20, 2026
6w ago
Press Release
NEUTRAL ★ 3/10
$13.17 $14.25▲ +8.20%▲ +4.00%$15.46 (+17.39%)
Mar 20, 2026
11w ago
Press Release
BULLISH ★ 7/10
$14.88 $13.17▼ −11.46%▼ −20.78%$15.46 (+3.93%)
Showing 4 of 4

US Market Status

Market Closed — Opens Mon (14h 54m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access